Topic: clinical research collaboration
GlaxoSmithKline is pushing forward into a phase 3 for its antibiotic work as governments continue to warn of an antibiotic-resistant future.
Britain-based Big Pharma AstraZeneca has penned a new collab with Belgium’s N-SIDE for its clinical studies.
The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.
Bayer tapped Sensyne Health to sift through patient data from the NHS and apply the findings to its cardiovascular disease pipeline.
Parexel is looking to bolster its clinical trial work and compliance by signing a new deal with CluePoints.
Abbott pledged to provide its neuromodulation tech for the public-private NIH research effort.
PerkinElmer signed on to Accenture’s life science ecosystem to integrate its tech into the cloud-based platform’s drug discovery efforts.
Concerto HealthAI has inked its second real-world data collaboration with a Big Pharma company in as many weeks.
The BRACAnalysis CDx test will be used to hunt for germline BRCA mutations in men eligible for the Big Pharmas’ PARP-inhibiting Lynparza therapy.
AstraZeneca has signed on to be a founding partner for a new life sciences research hub in China, to be housed just west of Shanghai.